Paper23912930
Endothelin antagonism and its role in the treatment of hypertension.
Moorhouse RC and 3 others. Curr Hypertens Rep, 2013. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Endothelin antagonism and its role in the treatment of hypertension. Papers, record 23912930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23912930
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Endothelin Receptor Antagonists | Major topic |
| Endothelin-1 | Major topic |
| Hypertension | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Animals | |
| Blood Pressure | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0901697 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11897771 | Effect of endothelin blockade on basal and stimulated forearm blood flow in patients with essential hypertension. | Hypertension | 2002 | https://conductscience.org/library/papers/11897771 | PubMed |
| 2 | 8147891 | Clearance of circulating endothelin-1 by ETB receptors in rats. | Biochem Biophys Res Commun | 1994 | https://conductscience.org/library/papers/8147891 | PubMed |
| 3 | 15113749 | Endothelin stimulates endothelial nitric oxide synthase expression in the thick ascending limb. | Am J Physiol Renal Physiol | 2004 | https://conductscience.org/library/papers/15113749 | PubMed |
| 4 | 2403657 | Increased plasma endothelin level in patients with essential hypertension. | N Engl J Med | 1990 | https://conductscience.org/library/papers/2403657 | PubMed |
| 5 | 23245609 | A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. | Lancet | 2012 | https://conductscience.org/library/papers/23245609 | PubMed |
| 6 | 21357275 | Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease. | Hypertension | 2011 | https://conductscience.org/library/papers/21357275 | PubMed |
| 7 | 19506099 | Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. | Hypertension | 2009 | https://conductscience.org/library/papers/19506099 | PubMed |
| 8 | 8355464 | Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. | Kidney Int | 1993 | https://conductscience.org/library/papers/8355464 | PubMed |
| 9 | 9826706 | Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9826706 | PubMed |
| 10 | 2565518 | Plasma endothelin levels in patients with uraemia. | Lancet | 1989 | https://conductscience.org/library/papers/2565518 | PubMed |
| 11 | 15466627 | Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. | Circulation | 2004 | https://conductscience.org/library/papers/15466627 | PubMed |
| 12 | 15644875 | Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo. | Br J Pharmacol | 2005 | https://conductscience.org/library/papers/15644875 | PubMed |
| 13 | 12743011 | Effects of endothelin-1 and endothelin-1 receptor blockade on cardiac output, aortic pressure, and pulse wave velocity in humans. | Hypertension | 2003 | https://conductscience.org/library/papers/12743011 | PubMed |
| 14 | 16157796 | Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats. | Hypertension | 2005 | https://conductscience.org/library/papers/16157796 | PubMed |
| 15 | 14764893 | Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/14764893 | PubMed |
| 16 | 23816034 | Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. | Am Heart J | 2013 | https://conductscience.org/library/papers/23816034 | PubMed |
| 17 | 11399655 | Evidence for endothelin involvement in the response to high salt. | Am J Physiol Renal Physiol | 2001 | https://conductscience.org/library/papers/11399655 | PubMed |
| 18 | 20823379 | Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. | Hypertension | 2010 | https://conductscience.org/library/papers/20823379 | PubMed |
| 19 | 7916401 | Contribution of endogenous generation of endothelin-1 to basal vascular tone. | Lancet | 1994 | https://conductscience.org/library/papers/7916401 | PubMed |
| 20 | 20921430 | Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial. | Hypertension | 2010 | https://conductscience.org/library/papers/20921430 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41373585 | Current Knowledge About Aprocitentan in Hypertension. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373585 | PubMed |
| 38869007 | The role of sacubitril/valsartan in abnormal renal function patients combined with heart failure: a meta-analysis and systematic analysis. | Ren Fail | 2024 | https://conductscience.org/library/papers/38869007 | PubMed |
| 35498305 | LC-MS analysis of Myrica rubra extract and its hypotensive effects via the inhibition of GLUT 1 and activation of the NO/Akt/eNOS signaling pathway. | RSC Adv | 2020 | https://conductscience.org/library/papers/35498305 | PubMed |
| 34251649 | Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension. | Cardiol Ther | 2021 | https://conductscience.org/library/papers/34251649 | PubMed |
| 33127751 | Functional Interaction of Endothelin Receptors in Mediating Natriuresis Evoked by G Protein-Coupled Estrogen Receptor 1. | J Pharmacol Exp Ther | 2021 | https://conductscience.org/library/papers/33127751 | PubMed |
| 32747363 | Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma. | Cancer Res | 2020 | https://conductscience.org/library/papers/32747363 | PubMed |
| 32295540 | Aggravated endothelial endocrine dysfunction and intimal thickening of renal artery in high-fat diet-induced obese pigs following renal denervation. | BMC Cardiovasc Disord | 2020 | https://conductscience.org/library/papers/32295540 | PubMed |
| 30902047 | Acute changes in morphology and renal vascular relaxation function after renal denervation using temperature-controlled radiofrequency catheter. | BMC Cardiovasc Disord | 2019 | https://conductscience.org/library/papers/30902047 | PubMed |
| 30662649 | Long-term renal sympathetic denervation ameliorates renal fibrosis and delays the onset of hypertension in spontaneously hypertensive rats. | Am J Transl Res | 2018 | https://conductscience.org/library/papers/30662649 | PubMed |
| 27667708 | Drug Treatment of Hypertension: Focus on Vascular Health. | Drugs | 2016 | https://conductscience.org/library/papers/27667708 | PubMed |
| 26956245 | Endothelin. | Pharmacol Rev | 2016 | https://conductscience.org/library/papers/26956245 | PubMed |
| 26448026 | Inverse Correlation Between Plasma Adropin and ET-1 Levels in Essential Hypertension: A Cross-Sectional Study. | Medicine (Baltimore) | 2015 | https://conductscience.org/library/papers/26448026 | PubMed |
| 25725491 | Cre recombinase-regulated Endothelin1 transgenic mouse lines: novel tools for analysis of embryonic and adult disorders. | Dev Biol | 2015 | https://conductscience.org/library/papers/25725491 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EDN1 | 1906 | PubTator's text mining | https://conductscience.org/library/genes/1906 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23912930
GET https://conductscience.org/api/papers/v1/23912930/references?page=2